ParadiseJ., “Evaluating Oversight of Human Drugs and Medical Devices: A Case Study of the FDA and Implications for Nanobiotechnology,”Journal of Law, Medicine & Ethics37, no. 4 (2009): 598–624.
KahanD. M., Biased Assimilation, Polarization, and Cultural Credibility: An Experimental Study of Nanotechnology Risk Perceptions, Project on Emerging Nanotechnologies, Woodrow Wilson International Center for Scholars, February 4, 2008, available at <http://www.nanotechproject.org/publications/archive/yale2/> (last visited August 18, 2009).
See websiteWebMd, “Protect Your Health,”available at <http://www.webmd.com/fda/protect-your-health/default.htm> (last visited August 18, 2009). While the FDA website has about 6 million new visitors each month, WebMD has nearly 50 million.
11.
ScheufeleD. A.BrossardD., “Nanotechnology as a Moral Issue? Religion and Science in the U.S.,”Professional Ethics ReportXXI, no. 1 (Winter 2008): 1–3, at 2, available at <http://www.aaas.org/spp/sfrl/per/newper52.shtml> (last visited August 18, 2009).
12.
See Peter D. Hart Research Associates, supra note 8, at 3.
13.
See ScheufeleBrossard, supra note 11.
14.
GarciaJ. L. A., quoted in FrankelM. S., Viewing Science and Technology through a Cultural Prism (Washington, D.C.: AAAS, 1993): at 4.